Skip to main content
AER CoverageIndependent Research
Dexcom, Inc. logo

Dexcom, Inc.

Equity Research & Valuation

Ticker
DXCM
Exchange
NASDAQ
Country
United States

Healthcare · Medical Devices / Continuous Glucose Monitoring

Business Overview

Dexcom, Inc. is a global medical-device company specializing in the design, development, and commercialization of continuous glucose monitoring systems for diabetes and metabolic health. Its portfolio includes the G-series platforms, Dexcom ONE/ONE+, and Stelo, supported by direct, distributor, and digital channels across the United States and international markets.

Sector
Healthcare
Industry
Medical Devices / Continuous Glucose Monitoring
Coverage Initiated
December 1, 2025
Coverage Type
Independent Research

Price History

AER Valuation

Fair value and valuation analysis for Dexcom, Inc., based on AER's latest published valuation research.

Illustrative Valuation
$78.40
Market Price at Publication
$63.50
Valuation Methodology
Discounted Cash Flow
Valuation Notes
The illustrative valuation reflects the assumptions and execution framework detailed in the report and is not a price target or investment recommendation.
Source: Initiation Report · View Valuation Research →

Dexcom, Inc. Equity Research

Alliance Equity Research provides ongoing equity research on Dexcom, Inc. (DXCM), including published company analysis and research updates.

Initiation ReportIndependent Research38 pagesView Report
Dexcom Office

Dominant CGM Franchise Leveraging Technology, Coverage Expansion, and Consumer Tailwinds to Sustain Multi-Year Growth

Initiation coverage examining CGM market leadership, product strategy, reimbursement expansion, recurring sensor economics, international growth, valuation summary, and key risks.

Dexcom, Inc. Research Archive

  1. Initiation ReportCoverage Initiation38 pagesView Research →
    Dexcom Office

    Dominant CGM Franchise Leveraging Technology, Coverage Expansion, and Consumer Tailwinds to Sustain Multi-Year Growth

    Initiation coverage examining CGM market leadership, product strategy, reimbursement expansion, recurring sensor economics, international growth, valuation summary, and key risks.

Fundamentals

Market information is supplied by TradingView and may be delayed or unavailable for certain exchanges or instruments. It does not constitute investment advice.